T. Rowe Price Health Sciences Fund

Frequently Asked Questions About PRHSX

What does PRHSX invest in?

This fund typically allocates a minimum of 80% of its total net assets (including any borrowed capital utilized for investment purposes) to the common stock shares of businesses within the health sciences domain. This includes companies focused on the research, development, manufacturing, or distribution of offerings related to healthcare, medicine, or the broader life sciences. While the portfolio has the liberty to invest in companies of any market capitalization, most of its holdings are projected to be in large- and medium-sized corporations. The fund operates as a non-diversified investment vehicle.

What is the expense ratio of PRHSX?

T. Rowe Price Health Sciences Fund (PRHSX) charges an expense ratio of 0.83%. This is the annual fee deducted from fund assets to cover management and operations.

How big is PRHSX?

T. Rowe Price Health Sciences Fund (PRHSX) manages $13.11B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is PRHSX actively managed or an index fund?

PRHSX is actively managed — the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (PRHSX's is 0.83%) in exchange for the discretion to over- or under-weight positions.

When was PRHSX launched?

T. Rowe Price Health Sciences Fund (PRHSX) launched in December 1995 and is managed by T. Rowe Price.

How has PRHSX performed?

PRHSX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.